Adopted Trials - Lymphoma (Hodgkins)
Acronym: SHIELD (VEPEMB)
Full Title
A phase II study of vinblastine, endoxana (cyclophosphamide), procarbazine, prednisolone, etoposide, mitoxantrone and bleomycin in patients with Hodgkin's lymphoma aged over 60 years.
Treatment: Chemotherapy
Phase: 2
Current status: Closed to recruitment - in follow-up
Chief Investigator: Prof Stephen John Proctor
Type of trial: Early Phase
Website: http://www.shieldstudy.co.uk/
Acronym: Escalated ABVD
Full Title
A phase I study to investigate dose escalation of doxorubicin in cycles 1-3 of ABVD chemotherapy for Hodgkin lymphoma and to correlate this with molecular markers of tumour response and toxicity
Treatment: Technology
Phase: 1
Current status: Open to recruitment
Chief Investigator: Prof John Radford
Type of trial: New Technologies
Website:
